Literature DB >> 17276533

A population-based case-cohort study of the risk of myocardial infarction following radiation therapy for breast cancer.

Lawrence F Paszat1, Katherine A Vallis, Veronique M A Benk, Patti A Groome, William J Mackillop, Andreas Wielgosz.   

Abstract

OBJECTIVE: To describe the risk of acute myocardial infarction (AMI) after radiation therapy (RT) for breast cancer (BrCa) in an exposed population.
METHODS: We identified and validated cases of AMI (vAMI), by electrocardiographic or enzyme criteria, among all 6680 women who received post-operative RT following lumpectomy or mastectomy, within 12 months following diagnosis of BrCa between 1982 and 1988 in Ontario, Canada. We identified women without vAMI whose death certification was ascribed to AMI (dAMI). We abstracted risk factors and treatment exposures for a random sample of women from the 6680, and for all with vAMI or dAMI. The hazards of vAMI and of dAMI were estimated using multivariate Cox proportional hazards models, corrected for study design.
RESULTS: We validated 121 cases of vAMI and identified 92 cases of dAMI. The risk of vAMI associated with RT to the left breast HR=1.96 (1.09,3.54) among women at age >/= 60 at time of RT, adjusted for history of smoking and prior MI. The adjusted HR dAMI=1.90 (1.08,3.35) for exposure to anterior internal mammary node (IMC) RT. Among women who received anterior left breast boost RT, increasing area of the boost is associated with adjusted HR vAMI=1.02 (1.00,1.03)/cm(2), and adjusted HR dAMI=1.02 (1.01,1.03)/cm(2).
CONCLUSION: The risks of vAMI and dAMI following RT for BrCa are related to anatomic sites of RT (left breast, area of anterior left breast boost field, and anterior IMC field).

Entities:  

Mesh:

Year:  2007        PMID: 17276533     DOI: 10.1016/j.radonc.2007.01.004

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  20 in total

1.  Radiation dose associated with renal failure mortality: a potential pathway to partially explain increased cardiovascular disease mortality observed after whole-body irradiation.

Authors:  Michael Jacob Adams; Eric J Grant; Kazunori Kodama; Yukiko Shimizu; Fumiyoshi Kasagi; Akihiko Suyama; Ritsu Sakata; Masazumi Akahoshi
Journal:  Radiat Res       Date:  2011-12-07       Impact factor: 2.841

Review 2.  Second malignant neoplasms and cardiovascular disease following radiotherapy.

Authors:  Lois B Travis; Andrea K Ng; James M Allan; Ching-Hon Pui; Ann R Kennedy; X George Xu; James A Purdy; Kimberly Applegate; Joachim Yahalom; Louis S Constine; Ethel S Gilbert; John D Boice
Journal:  J Natl Cancer Inst       Date:  2012-02-06       Impact factor: 13.506

3.  Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?

Authors:  Jennifer K Hockings; Jessica A Castrillon; Feixiong Cheng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

4.  Acute effects of chemoradiation on cardiac function in oesophageal cancer: a MUGA scan and echo-based study.

Authors:  Raviteja Miriyala; Rakesh Kapoor; Amit Bahl; Anish Bhattacharya; Ajay Bahl; Parsee Tomar
Journal:  Heart Asia       Date:  2015-10-05

5.  Is there a dose-response relationship for heart disease with low-dose radiation therapy?

Authors:  Eugene Chung; James R Corbett; Jean M Moran; Kent A Griffith; Robin B Marsh; Mary Feng; Reshma Jagsi; Marc L Kessler; Edward C Ficaro; Lori J Pierce
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-09-27       Impact factor: 7.038

Review 6.  Current role of modern radiotherapy techniques in the management of breast cancer.

Authors:  Gokhan Ozyigit; Melis Gultekin
Journal:  World J Clin Oncol       Date:  2014-08-10

7.  Visualisation of the left anterior descending coronary artery on CT images used for breast radiotherapy planning.

Authors:  S Vennarini; N Fournier-Bidoz; C Aristei; C E de Almeida; V Servois; F Campana; V Mosseri; A Fourquet; Y M Kirova
Journal:  Br J Radiol       Date:  2013-02-25       Impact factor: 3.039

Review 8.  Breast cancer therapy-associated cardiovascular disease.

Authors:  Timothy M Zagar; Daniela M Cardinale; Lawrence B Marks
Journal:  Nat Rev Clin Oncol       Date:  2015-11-24       Impact factor: 66.675

Review 9.  [Is cardiotoxicity still an issue after breast-conserving surgery and could it be reduced by multifield IMRT?].

Authors:  Frank Lohr; Felix Heggemann; Theano Papavassiliu; Mostafa El-Haddad; Oliver Tomé; Dietmar Dinter; Barbara Dobler; Uta Kraus-Tiefenbacher; Martin Borggrefe; Frederik Wenz
Journal:  Strahlenther Onkol       Date:  2009-04-16       Impact factor: 3.621

10.  Evaluation of cardiotoxicity five years after 2D planned, non-simulated, radiation therapy for left breast cancer.

Authors:  Kyriaki Pistevou-Gompaki; Apostolos Hatzitolios; Nikos Eleftheriadis; Evaggelos Boultoukas; George Ntaios; Ioannis Andronikidis; Ioannis Tzitzikas
Journal:  Ther Clin Risk Manag       Date:  2008-12       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.